Literature DB >> 30594456

Rare variants in Protein tyrosine phosphatase, receptor type A (PTPRA) in schizophrenia: Evidence from a family based study.

Jibin John1, Prachi Kukshal1, Aditya Sharma1, Triptish Bhatia2, V L Nimgaonkar3, S N Deshpande2, B K Thelma4.   

Abstract

The contribution of both common and rare risk variants to the genetic architecture of schizophrenia (SZ) has been documented in genome-wide association studies, whole exome and whole genome sequencing approaches. As SZ is highly heritable and segregates in families, highly penetrant rare variants are more likely to be identified through analyses of multiply affected families. Further, much of the gene mapping studies in SZ have utilized individuals of Caucasian ancestry. Analysis of other ethnic groups may be informative. In this study, we aimed at identification of rare, penetrant risk variants utilizing whole exome sequencing (WES) in a three-generation Indian family with multiple members affected. Filtered data from WES, combined with in silico analyses revealed a novel heterozygous missense variant (NM_080841:c.1730C>G:p.T577R; exon18) in Protein tyrosine phosphatase, receptor type A (PTPRA 20p13). The variant was located in an evolutionarily conserved position and predicted to be damaging. Screening for variants in this gene in the WES data of an independent SZ cohort (n = 350) of matched ethnicity, identified five additional rare missense variants with MAF < 0.003, which were also predicted to be damaging. In conclusion, the rare missense variants in PTPRA identified in this study could confer risk for SZ. This has also derived support from concordant data from prior linkage and association, as well as animal studies which indicated a role for PTPRA in glutamate function. Crown
Copyright © 2018. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30594456      PMCID: PMC7321970          DOI: 10.1016/j.schres.2018.12.012

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  57 in total

1.  Resequencing and association analysis of PTPRA, a possible susceptibility gene for schizophrenia and autism spectrum disorders.

Authors:  Jingrui Xing; Chenyao Wang; Hiroki Kimura; Yuto Takasaki; Shohko Kunimoto; Akira Yoshimi; Yukako Nakamura; Takayoshi Koide; Masahiro Banno; Itaru Kushima; Yota Uno; Takashi Okada; Branko Aleksic; Masashi Ikeda; Nakao Iwata; Norio Ozaki
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

2.  Truncating mutations in RBM12 are associated with psychosis.

Authors:  Stacy Steinberg; Steinunn Gudmundsdottir; Gardar Sveinbjornsson; Jaana Suvisaari; Tiina Paunio; Minna Torniainen-Holm; Michael L Frigge; Gudrun A Jonsdottir; Johanna Huttenlocher; Sunna Arnarsdottir; Oddur Ingimarsson; Magnus Haraldsson; Thorarinn Tyrfingsson; Thorgeir E Thorgeirsson; Augustine Kong; Gudmundur L Norddahl; Daniel F Gudbjartsson; Engilbert Sigurdsson; Hreinn Stefansson; Kari Stefansson
Journal:  Nat Genet       Date:  2017-06-19       Impact factor: 38.330

3.  Contribution of Kv1.2 voltage-gated potassium channel to D2 autoreceptor regulation of axonal dopamine overflow.

Authors:  Stephanie Fulton; Dominic Thibault; Jose A Mendez; Nicolas Lahaie; Emanuele Tirotta; Emiliana Borrelli; Michel Bouvier; Bruce L Tempel; Louis-Eric Trudeau
Journal:  J Biol Chem       Date:  2011-01-13       Impact factor: 5.157

4.  Possible role of rare variants in Trace amine associated receptor 1 in schizophrenia.

Authors:  Jibin John; Prachi Kukshal; Triptish Bhatia; K V Chowdari; V L Nimgaonkar; S N Deshpande; B K Thelma
Journal:  Schizophr Res       Date:  2017-02-24       Impact factor: 4.939

5.  Protein-tyrosine phosphatase alpha acts as an upstream regulator of Fyn signaling to promote oligodendrocyte differentiation and myelination.

Authors:  Pei-Shan Wang; Jing Wang; Zhi-Cheng Xiao; Catherine J Pallen
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

6.  Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network.

Authors:  Suleyman Gulsuner; Tom Walsh; Amanda C Watts; Ming K Lee; Anne M Thornton; Silvia Casadei; Caitlin Rippey; Hashem Shahin; Vishwajit L Nimgaonkar; Rodney C P Go; Robert M Savage; Neal R Swerdlow; Raquel E Gur; David L Braff; Mary-Claire King; Jon M McClellan
Journal:  Cell       Date:  2013-08-01       Impact factor: 41.582

7.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

8.  Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness.

Authors:  O R Homann; K Misura; E Lamas; R W Sandrock; P Nelson; S I McDonough; L E DeLisi
Journal:  Mol Psychiatry       Date:  2016-03-22       Impact factor: 15.992

9.  GRIN3B missense mutation as an inherited risk factor for schizophrenia: whole-exome sequencing in a family with a familiar history of psychotic disorders.

Authors:  Tobias Hornig; Björn Grüning; Kousik Kundu; Torsten Houwaart; Rolf Backofen; Knut Biber; Claus Normann
Journal:  Genet Res (Camb)       Date:  2017-01-30       Impact factor: 1.588

10.  De novo variants in sporadic cases of childhood onset schizophrenia.

Authors:  Amirthagowri Ambalavanan; Simon L Girard; Kwangmi Ahn; Sirui Zhou; Alexandre Dionne-Laporte; Dan Spiegelman; Cynthia V Bourassa; Julie Gauthier; Fadi F Hamdan; Lan Xiong; Patrick A Dion; Ridha Joober; Judith Rapoport; Guy A Rouleau
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246

View more
  4 in total

1.  Multiple rare inherited variants in a four generation schizophrenia family offer leads for complex mode of disease inheritance.

Authors:  Jibin John; Upasana Bhattacharyya; Navneesh Yadav; Prachi Kukshal; Triptish Bhatia; V L Nimgaonkar; Smita N Deshpande; B K Thelma
Journal:  Schizophr Res       Date:  2019-12-05       Impact factor: 4.939

2.  Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control study.

Authors:  Hirofumi Igeta; Yuichiro Watanabe; Ryo Morikawa; Masashi Ikeda; Ikuo Otsuka; Satoshi Hoya; Masataka Koizumi; Jun Egawa; Akitoyo Hishimoto; Nakao Iwata; Toshiyuki Someya
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-19       Impact factor: 2.570

3.  Does a rare mutation in PTPRA contribute to the development of Parkinson's disease in an Australian multi-incident family?

Authors:  Melissa A Hill; Steven R Bentley; Tara L Walker; George D Mellick; Stephen A Wood; Alex M Sykes
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

4.  Rare Pathogenic Variants in Genes Implicated in Glutamatergic Neurotransmission Pathway Segregate with Schizophrenia in Pakistani Families.

Authors:  Ambrin Fatima; Uzma Abdullah; Muhammad Farooq; Yuan Mang; Mana M Mehrjouy; Maria Asif; Zafar Ali; Niels Tommerup; Shahid M Baig
Journal:  Genes (Basel)       Date:  2021-11-26       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.